Form 8-K - Current report:
SEC Accession No. 0001558370-20-001319
Filing Date
2020-02-25
Accepted
2020-02-25 16:15:28
Documents
3
Period of Report
2020-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 35410
2 EX-99.1 ex-99d1.htm EX-99.1 186003
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 17887
  Complete submission text file 0001558370-20-001319.txt   247308
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 20650817
SIC: 2834 Pharmaceutical Preparations